Atrium Therapeutics, Inc. · NASDAQ:RNA
Winslow Brendan R. received 30,000 Atrium Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Winslow Brendan R. (Chief Financial Officer) received 30,000 Atrium Therapeutics, Inc. shares as an award, leaving 43,601 shares. Filed Apr 22, 2026 (Form 4).
- Awarded
- 30,000 shares
- Holding after
- 43,601 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Award | 30,000 | 43,601 | Direct |
Source
Related
- Atrium Therapeutics, Inc.
- Winslow Brendan R.
- Atrium Therapeutics, Inc. shareholders
- Form 4 · Winslow Brendan R. · Sep 22, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026